Interleukin-18 resistance in patients with obesity and type 2 diabetes mellitus

International Journal of Obesity

Volumn 32, Issue 9, 2008, Pages 1407-1414

  Zilverschoon, G R C ^a   Tack, C J ^a   Joosten, L A B ^a   Kullberg, B J ^a   Van Der Meer, J W M ^a   Netea, M G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cytokine; Interleukin 18; Type 2 diabetes

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR ALPHA; INTERLEUKIN 18 RECEPTOR BETA; RECOMBINANT INTERLEUKIN 18;

ADULT; ARTICLE; CANDIDA ALBICANS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; MALE; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; STAPHYLOCOCCUS AUREUS;

ADULT; CANDIDA ALBICANS; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-18; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; MONOCYTES; OBESITY; RECOMBINANT PROTEINS; STAPHYLOCOCCUS AUREUS; THINNESS;

BACTERIA (MICROORGANISMS);

EID: 51849099326     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2008.109     Document Type: Article

References (39)

1. Bazan JF, Timans JC, Kastelein RA. A newly defined interleukin-1? Nature 1996; 379: 591.
2. Dinarello CA, Novick D, Puren AJ, Fantuzzi G, Shapiro L, Mühl H et al. Overview of interleukin-18: more than an interferon-gamma inducing factor. J Leuk Biol 1998; 63: 658-664.
3. Fantuzzi G, Dinarello CA. Interleukin-18 and interleukin-1beta: two cytokine susbstrates for ICE (caspase-1). J Clin Immunol 1999; 19: 1-11.
4. Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A et al. Caspase-1 processes IFN-g-inducing factor and regulates LPS-induced IFN-γ production. Nature 1997; 386: 619-623.
5. Hung J, McQuillan BM, Chapman CM, Thompson PL, Beilby JP. Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance. Arterioscler Thromb Vasc Biol 2005; 25: 1268-1273.
6. Fischer CP, Perstrup LB, Berntsen A, Eskildsen P, Pedersen BK. Elevated plasma interleukin-18 is a marker of insulin-resistance in type 2 diabetic and non-diabetic humans. Clin Immunol 2005; 117: 152-160.
7. Escobar-Morreale HF, Botella-Carretero JI, Villuendas G, Sancho J, San Millan JL. Serum interleukin-18 concentrations are increased in the plycystic ovary syndrome: relationship to insulin resistance and obesity. J Clin Endocrinol Metab 2004; 89: 806-811.
8. Bruun JM, Stallknecht B, Helge JW, Richelsen B. Interleukin-18 in plasma and adipose tissue: effects of obesity, insulin resistance, and weight loss. Eur J Endocrinol 2007; 157: 465-471.
9. Leick L, Lindegaard B, Stensvold D, Plomgaard P, Saltin B, Pilegaard H. Adipose tissue interleukin-18 mRNA and plasma interleukin-18: effect of obesity and exercise. Obesity 2007; 15: 356-363.
10. Thompson SR, Sanders J, Stephens JW, Miller GJ, Humphries SE. A common interleukin 18 haplotype is associated with higher body mass index in subjects with diabetes and coronary heart disease. Metabolism 2007; 56: 662-669.
11. Vilarrasa N, Vendrell J, Sanchez-Santos R, Broch M, Megia A, Masdevall C et al. Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alpha receptors, C-reactive protein and adiponectin in morbidly obese patients. Clin Endocrinol 2007; 67: 679-686.
12. Netea MG, Joosten LA, Lewis E, Jensen DR, Voshol PJ, Kullberg BJ et al. Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nat Med 2006; 12: 650-656.
13. Zorrilla EP, Sanchez-Alavez M, Sugama S, Brennan M, Fernandez R, Bartfai T et al. Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency. Proc Natl Acad Sci USA 2007; 104: 11097-11102.
14. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med 1999; 341: 1906-1912.
15. Falagas ME, Kompoti M. Obesity and infection. Lancet Infect Dis 2006; 6: 438-446.
16. Hopkins PN, Hunt SC, Wu LL, Williams GH, Williams RR. Hypertension, dyslipidemia and insulin resistance: links in a chain or spokes on a wheel ? Curr Opin Lipidol 1996; 7: 241-253.
17. Root HF. The association of diabetes and tuberculosis. N Engl J Med 1934; 210: 1-13.
18. Alisjahbana B, van Crevel R, Sahiratmadja E, den Heijer M, Maya A, Istriana E et al. Diabetes mellitus is strongly associated with tuberculosis in Indonesia. Int J Tuberc Lung Dis 2006; 10: 696-700.
19. Valerius NH, Eff C, Hansen NE, Karle H, Nerup J, Søeberg B et al. Neutrophil and lymphocyte function in patients with diabetes mellitus. Acta Med Scand 1982; 211: 463-467.
20. Delamaire M, Maugendre D, Moreno M, Le Goff M-C, Allanic H, Genetet B. Impaired leukocyte functions in diabetic patients. Diabetic Med 1997; 14: 29-34.
21. Gallacher SJ, Thomson G, Fraser WD, Fisher BM, Gemmell CG, MacCuish AC. Neutrophil bactericidal function in diabetes mellitus: evidence for association with blood glucose control. Diabet Med 1995; 12: 916-920.
22. Tsiavou A, Hatziagelaki E, Chaidaroglou A, Koniavitou K, Degiannis D, Raptis SA. Correlation between intracellular interferon-gamma (IFN-gamma) production by CD4+ and CD8+ lymphocytes and IFN-gamma gene polymorphism in patients with type 2 diabetes mellitus and latent autoimmune diabetes of adults (LADA). Cytokine 2005; 31: 135-141.
23. Murray HW. Interferon-gamma and host antimicrobial defense: current and future clinical applications. Am J Med 1994; 97: 459-467.
24. Fontana L, Eagon JC, Colonna M, Klein S. Impaired mononuclear cell immune function in extreme obesity is corrected by weight loss. Rejuvenation Res 2007; 10: 41-46.
25. Tsiavou A, Degiannis D, Hatziagelaki E, Koniavitou K, Raptis S. Flow cytometric detection of intracellular IL-12 release: in vitro effect of widely used immunosuppressants. Int Immunopharmacol 2002; 2: 1713-1720.
26. Tsukaguchi K, Okamura H, Ikuno M, Kobayashi A, Fukuoka A, Takenaka H et al. [The relation between diabetes mellitus and IFN-gamma, IL-12 and IL-10 productions by CD4+ alpha beta T cells and monocytes in patients with pulmonary tuberculosis]. Kekkaku 1997; 72: 617-622.
27. Grebenchtchikov N, van der Ven-Jongekrijg J, Pesman GJ, Geurts-Moespot A, van der Meer JW, Sweep FC. Development of a sensitive ELISA for the quantification of human tumour necrosis factor-alpha using 4 polyclonal antibodies. Eur Cytokine Netw 2005; 16: 215-222.
28. Yoshimoto T, Takeda K, Tanaka T, Ohkusu K, Kashiwamura S, Okamura H et al. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J Immunol 1998; 161: 3400-3407.
29. Draznin B. Molecular mechanisms of insulin resistance: serine phosphorylation of insulin receptor substrate-1 and increased expression of p85alpha: the two sides of a coin. Diabetes 2006; 55: 2392-2397.
30. Karlsson HK, Zierath JR. Insulin signaling and glucose transport in insulin resistant human skeletal muscle. Cell Biochem Biophys 2007; 48: 103-113.
31. Inoue H, Ogawa W, Ozaki M, Haga S, Matsumoto M, Furukawa K et al. Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo. Nature Med 2004; 10: 168-174.
32. Netea MG, Joosten LAB, Lewis E, Jensen DR, Voshol PJ, Kullberg BJ et al. Deficiency of interleukin-18 in mice leads to obesity, insulin resistance, and hyperglycemia, through defective STAT3-mediated signaling. Nature Med 2006; 12: 650-656.
33. Kalina U, Kauschat D, Koyama N, Nuernberger H, Ballas K, Koschmieder S et al. IL-18 activates STAT3 in the Natural Killer cell line 92, augments cytotoxic activity, and mediates IFN production by the stress kinase p38 and by the extracellular regulated kinases p44/erk-1 and p42/erk-21. J Immunol 2000; 165: 1307-1313.
34. Sugimoto N, Nakahira M, Ahn HJ, Micallef M, Hamaoka T, Kurimoto M et al. Differential requirements for JAK2 and TYK2 in T cell proliferation and IFN-gamma production induced by IL-12 alone or together with IL-18. Eur J Immunol 2003; 33: 243-251.
35. Kojima H, Takeuchi M, Ohta T, Nishida Y, Arai N, Ikeda M et al. Interleukin-18 activates the IRAK-TRAF6 pathway in mouse EL-4 cells. Biochem Biophys Res Commun 1998; 244: 183-186.
36. Kumar A, Takada Y, Boriek AM, Aggarwal BB. Nuclear factor-kappaB: its role in health and disease. J Mol Med 2004; 82: 434-448.
37. Koziel H, Koziel MJ. Pulmonary complications of diabetes mellitus: pneumonia. Infect Dis Clin North Am 1995; 9: 65-96.
38. Vellenga E, Uyl-de Groot CA, de Wit R, Keizer HJ, Löwenberg B, ten Haaft MA et al. Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia. J Clin Oncol 1996; 14: 619-627.
39. Sentochnik DE. Deep soft-tissue infections in diabetic patients. Infect Dis Clin North Am 1995; 9: 53-64.